George Budwell
George Budwell, PhD, is a contributing Motley Fool biotechnology and technology analyst covering disruptive innovators in healthcare, defense, and artificial intelligence. He also writes on portfolio theory, dividend stocks, and value investing. Prior to The Motley Fool, George was a freelance medical and science writer and a consultant for several life sciences hedge funds. Earlier in his career, he was an evolutionary biologist and completed postdoctoral fellowships at Kyoto University and Illinois State University. He holds a doctorate in evolutionary biology from Tulane University and a bachelor’s degree from Loyola University.
Recent Articles by George Budwell

How I'm Building My Quantum Computing Portfolio

5 AI Stocks to Load Up On in 2025

3 Incredible Dividend Growth Stocks to Buy Right Now

3 Reasons Nvidia Stock Is a Forever Buy and Hold

3 Incredible Growth Stocks I Can't Stop Buying

Is Nike a Top Buy in 2025?

This Unpopular Dividend Stock Is a Buy

Is Walmart Stock a Buy in 2025?

Is Rigetti Computing Stock a Buy in 2025?
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.